Shilpa Medicare is currently trading at RS 706.95, up by 12.80 points or 1.84% from its previous close of RS 694.15 on the BSE.

The stock opened at RS 700.05 and has touched an intraday high of RS 725.25 and a low of RS 700.05. A total of 6204 shares have been traded so far.

The BSE Group 'A' stock with a face value of RS 1 has registered a 52-week high of RS 959.95 on September 18, 2024, and a 52-week low of RS 419.10 on June 4, 2024. Over the last week, the stock traded between RS 725.25 and RS 603.00. The company's current market capitalization stands at RS 7017.96 crore.

Promoters hold 44.23% of the company's shares, while institutional and non-institutional investors hold 18.52% and 37.25% respectively.

The United States Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) to Shilpa Medicare’s 100% subsidiary, Shilpa Pharma Lifesciences’ Unit-1. The site has been classified as "Voluntary Action Indicated" (VAI) following an inspection conducted from March 3 to March 7, 2025.

Shilpa Medicare is known for manufacturing and exporting high-quality Active Pharmaceutical Ingredients (APIs), fine chemicals, intermediates, herbal products, and specialty chemicals, adhering strictly to international standards and utilizing advanced technologies.